In 2021, entrepeneur and IBS patient, Rudi van der Vlies consulted with Dr Simone Peters (founder of Mind + Gut Clinic, co-founder of Nerva, Monash University). Rudi was astonished to discover that despite the prevalence of IBS, no company was fully dedicated to addressing it. Determined to change that, he boldly stated, “If there isn’t a dedicated company focused on IBS, let us create one!”

At TUMME®, our vision is to become a life changing company that improves the quality of life of 10 million people who live with IBS by 2035.

Our purpose is clear – to support these patients, with evidence-based strategies, unwavering advocacy, and a community that advocates, uplifts, and inspires.

What sets us apart is our understanding that patients respond best to a multidisciplinary approach, including pharmaceuticals, dietary intervention and behavioural therapies. This reflects our core mission - to educate and empower individuals to help manage their symptoms and lead more fulfilling lives. 

Each of our products undergoes a meticulous journey, from conception to formulation, underpinned by the latest scientific research and clinical trials. Our approach is rigorous and evidence based.

"The Science" isn't just words - it's a testament to our dedication to making a tangible difference in the lives of those we serve, grounded in the principles of transparency, trust and transformative health solutions.